Evidence map›Paper›PMID 32181425›Full record

ArticleAnnals of hepato-biliary-pancreatic surgery2020

Long-term outcome of intraoperative radiofrequency ablation for hepatocellular carcinoma and its efficacy as a primary treatment.

Jongduk Kwon, Kwang-Sik Chun, In-Sang Song, Seok-Hwan Kim, Sunjong Han

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hepato-biliary-pancreatic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jongduk KwonDepartment of Surgery, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0001-5189-9130
Kwang-Sik ChunDepartment of Surgery, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0002-1530-8759
In-Sang SongDepartment of Surgery, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0001-8314-3346
Seok-Hwan KimDepartment of Surgery, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0003-0209-0444
Sunjong HanDepartment of Surgery, Chungnam National University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0002-1235-7459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDS/

aimsWe conducted this study to identify long-term outcomes following intraoperative radiofrequency ablation (IO-RFA) for hepatocellular carcinoma (HCC) and to reveal independent prognostic factors for survival.

methodsFrom December 1998 to February 2019, 183 patients underwent IO-RFA for HCC. These patients were divided into two groups according to whether RFA was done as a first-line (1-RFA group, n=106) or secondary-line (2-RFA group, n=77) treatment. Furthermore, we compared the survival outcomes between the 1-RFA and 2-RFA groups.

resultsThere were no significant differences in type of surgical approaches between the two groups (

conclusionsTherapeutic outcomes of IO-RFA were comparable to those of surgical resection. Additionally, 1-RFA might be an alternative treatment for naïve HCC in patients with uncompensated liver function and severe comorbidities.

Indexed as

First-lineHepatocellular carcinomaOutcomeRadiofrequency ablationSecond-line

Identifiers

PMID32181425
PMCPMC7061039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.